Lenvatinib is independently associated with the reduced...

  • Main
  • 2020 / 11
  • Lenvatinib is independently associated with the reduced...

Lenvatinib is independently associated with the reduced risk of progressive disease when compared to sorafenib in patients with advanced hepatocellular carcinoma

Kim, Soojin, Kim, Kyung Hyun, Kim, Beom Kyung, Park, Jun Yong, Ahn, Sang Hoon, Kim, Do Young, Kim, Seung Up
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of Gastroenterology and Hepatology
DOI:
10.1111/jgh.15355
Date:
November, 2020
File:
PDF, 900 KB
2020
Conversion to is in progress
Conversion to is failed